Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

On-demand webcast of expert faculty presentation on integrating bispecific antibodies across hematologic malignancies, including lymphoma and multiple myeloma, from the nursing perspective.

• Evaluate emerging safety and efficacy data on bispecific antibody therapeutics in the treatment of patients with hematologic malignancies

• Discuss prescribed bispecific antibody–based therapeutic strategies with patients with hematologic malignancies and their caregivers, taking into consideration current indications, safety profiles, and administration considerations

• Manage and mitigate adverse events associated with bispecific antibody treatment in patients with hematologic malignancies

• Identify patients with hematologic malignancies who may be eligible for ongoing clinical trials evaluating currently available and emerging bispecific antibodies

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Nicolle Rochino, PharmD, RPh, as noted below.​

Nicolle Rochino, PharmD, RPH: employee (relationship has ended): Novo Nordisk.